Oncopeptides AB (publ)
ONPPF · OTC
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Market Cap | $0 | $1 | $1 | $1 |
| - Cash | $0 | $0 | $0 | $0 |
| + Debt | $0 | $0 | $0 | $0 |
| Enterprise Value | $0 | $0 | $0 | $1 |
| Revenue | $0 | $0 | $0 | $0 |
| % Growth | -10.1% | 321.5% | -92.9% | – |
| Gross Profit | $0 | $0 | $0 | $0 |
| % Margin | 91.6% | 103.1% | 99.9% | 55.1% |
| EBITDA | -$0 | -$0 | -$0 | -$1 |
| % Margin | -895.8% | -657.6% | -3,825.7% | -1,188.1% |
| Net Income | -$0 | -$0 | -$0 | -$1 |
| % Margin | -899.3% | -707.3% | -4,044.9% | -1,209.1% |
| EPS Diluted | -1.87 | -2.76 | -4.11 | -19 |
| % Growth | 32.2% | 32.8% | 78.4% | – |
| Operating Cash Flow | -$0 | -$0 | -$0 | -$2 |
| Capital Expenditures | $0 | -$0 | -$0 | -$0 |
| Free Cash Flow | -$0 | -$0 | -$0 | -$2 |